New assays and reagents expand multiplexing capabilities, allowing researchers to analyze more cancer-related mutations and biomarkers in a single reaction.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.